MedPath

Fludeoxyglucose

These highlights do not include all the information needed to use Fludeoxyglucose F 18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F 18 Injection. Fludeoxyglucose F 18 Injection, for intravenous useInitial U.S. Approval: 2005

Approved
Approval ID

dfd91498-4bfc-4d45-a9a3-cee6153ae573

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 11, 2019

Manufacturers
FDA

THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH

DUNS: 110565913

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fludeoxyglucose F18

PRODUCT DETAILS

NDC Product Code13267-234
Application NumberNDA021870
Marketing CategoryC73594
Route of AdministrationINTRAVENOUS
Effective DateJuly 12, 2019
Generic NameFludeoxyglucose F18

INGREDIENTS (1)

FLUDEOXYGLUCOSE F-18Active
Quantity: 400 mCi in 1 mL
Code: 0Z5B2CJX4D
Classification: ACTIB
© Copyright 2025. All Rights Reserved by MedPath